Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 5
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

TP53 and MDM2 single nucleotide polymorphisms influence survival in non-del(5q) myelodysplastic syndromes

  • McGraw, Kathy L.
  • Cluzeau, Thomas
  • Sallman, David A.
  • Basiorka, Ashley A.
  • Irvine, Brittany A.
  • Ling, Zhang
  • Epling-Burnette, P. K.
  • Rollison, Dana E.
  • Mallo, Maria del Mar|||0000-0001-7741-498X
  • Sokol, Lubomir
  • Sole, F.|||0000-0002-3251-2161
  • Maciejewski, Jaroslaw|||0000-0002-6837-4346
  • List, Alan F.
Abstract:P53 is a key regulator of many cellular processes and is negatively regulated by the human homolog of murine double minute-2 (MDM2) E3 ubiquitin ligase. Single nucleotide polymorphisms (SNPs) of either gene alone, and in combination, are linked to cancer susceptibility, disease progression, and therapy response. We analyzed the interaction of TP53 R72P and MDM2 SNP309 SNPs in relationship to outcome in patients with myelodysplastic syndromes (MDS). Sanger sequencing was performed on DNA isolated from 208 MDS cases. Utilizing a novel functional SNP scoring system ranging from +2 to -2 based on predicted p53 activity, we found statistically significant differences in overall survival (OS) (p = 0.02) and progression-free survival (PFS) (p = 0.02) in non-del(5q) MDS patients with low functional scores. In univariate analysis, only IPSS and the functional SNP score predicted OS and PFS in non-del(5q) patients. In multivariate analysis, the functional SNP score was independent of IPSS for OS and PFS. These data underscore the importance of TP53 R72P and MDM2 SNP309 SNPs in MDS, and provide a novel scoring system independent of IPSS that is predictive for disease outcome.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Targeted deep sequencing improves outcome stratification in chronic myelomonocytic leukemia with low risk cytogenetic features

  • Palomo Sanchís, Laura|||0000-0003-3176-6271
  • García, Olga
  • Arnan, Montserrat
  • Xicoy, Blanca|||0000-0002-0295-1307
  • Fuster García, Francisco|||0000-0002-2528-6143
  • Cabezón, Marta|||0000-0001-5122-7481
  • Coll, Rosa|||0000-0003-0560-1254
  • Ademà, Vera|||0000-0001-6051-4378
  • Grau Cat, Javier
  • Jiménez, Maria-José
  • Pomares, Helena
  • Marcé, Silvia|||0000-0001-9128-6822
  • Mallo, Maria del Mar|||0000-0001-7741-498X
  • Millá, Fuensanta
  • Alonso, Esther
  • Sureda, Anna|||0000-0002-1238-6970
  • Gallardo, David|||0000-0003-1615-4592
  • Feliu Frasnedo, Evarist|||0000-0001-5780-3136
  • Ribera, Jose-Maria|||0000-0003-1042-6024
  • Sole, F.|||0000-0002-3251-2161
  • Zamora, Lurdes|||0000-0003-1713-7110
Clonal cytogenetic abnormalities are found in 20-30% of patients with chronic myelomonocytic leukemia (CMML), while gene mutations are present in.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Analysis of Intratumoral Heterogeneity in Myelodysplastic Syndromes with Isolated del(5q) Using a Single Cell Approach

  • Acha, Pamela|||0000-0002-4528-1219
  • Xicoy, Blanca|||0000-0002-0295-1307
  • Mallo, Maria del Mar|||0000-0001-7741-498X
  • Manzanares Mileo, Ana|||0000-0003-4125-4675
  • Grau Cat, Javier
  • Marcé, Silvia|||0000-0001-9128-6822
  • Granada, Isabel|||0000-0002-4275-0104
  • Rodríguez-Luaces, Marta|||0000-0001-9380-4179
  • Diez-Campelo, María|||0000-0002-1467-6779
  • Zamora, Lurdes|||0000-0003-1713-7110
  • Sole, F.|||0000-0002-3251-2161
  • Palomo Sanchís, Laura|||0000-0003-3176-6271
  • Fuster-Tormo, Francisco|||0000-0002-1220-6183
Myelodysplastic syndromes (MDS) are a heterogeneous group of hematological diseases. Among them, the most well characterized subtype is MDS with isolated chromosome 5q deletion (MDS del(5q)), which is the only one defined by a cytogenetic abnormality that makes these patients candidates to be treated with lenalidomide. During the last decade, single cell (SC) analysis has emerged as a powerful tool to decipher clonal architecture and to further understand cancer and other diseases at higher resolution level compared to bulk sequencing techniques. In this study, a SC approach was used to analyze intratumoral heterogeneity in four patients with MDS del(5q). Single CD34+CD117+CD45+CD19- bone marrow hematopoietic stem progenitor cells were isolated using the C1 system (Fluidigm) from diagnosis or before receiving any treatment and from available follow-up samples. Selected somatic alterations were further analyzed in SC by high-throughput qPCR (Biomark HD, Fluidigm) using specific TaqMan assays. A median of 175 cells per sample were analyzed. Inferred clonal architectures were relatively simple and either linear or branching. Similar to previous studies based on bulk sequencing to infer clonal architecture, we were able to observe that an ancestral event in one patient can appear as a secondary hit in another one, thus reflecting the high intratumoral heterogeneity in MDS del(5q) and the importance of patient-specific molecular characterization.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Targeted deep sequencing of CD34+ cells from peripheral blood can reproduce bone marrow molecular profile in myelodysplastic syndromes

  • Martin, Roman|||0000-0002-0535-3353
  • Acha, Pamela|||0000-0002-4528-1219
  • Ganster, Christina|||0000-0002-7566-5985
  • Palomo Sanchís, Laura|||0000-0003-3176-6271
  • Dierks, Sascha
  • Fuster-Tormo, Francisco|||0000-0002-1220-6183
  • Mallo, Maria del Mar|||0000-0001-7741-498X
  • Ademà, Vera|||0000-0001-6051-4378
  • Gómez-Marzo, Paula|||0000-0002-6829-9630
  • De Haro, Nuri|||0000-0002-2952-2924
  • Solanes, Neus|||0000-0002-5359-7598
  • Zamora, Lurdes|||0000-0003-1713-7110
  • Xicoy, Blanca|||0000-0002-0295-1307
  • Shirneshan, Katayoon
  • Flach, Johanna
  • Braulke, Friederike
  • Schanz, Julie
  • Kominowski, Arkadiusz
  • Stromburg, Martin
  • Brockmann, Alina
  • Trümper, Lorenz
  • Sole, F.|||0000-0002-3251-2161
  • Haase, Detlef|||0000-0001-7229-8000
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Pathophysiologic and clinical implications of molecular profiles resultant from deletion 5q

  • Ademà, Vera|||0000-0001-6051-4378
  • Palomo Sanchís, Laura|||0000-0003-3176-6271
  • Walter, Wencke
  • Mallo, Maria del Mar|||0000-0001-7741-498X
  • Hutter, Stephan|||0000-0003-2432-8898
  • La Framboise, Thomas
  • Arenillas, Leonor|||0000-0002-9020-8766
  • Meggendorfer, Manja
  • Radivoyevitch, Tomas
  • Xicoy, Blanca|||0000-0002-0295-1307
  • Pellagatti, Andrea
  • Haferlach, Claudia
  • Boultwood, Jacqueline|||0000-0002-4330-2928
  • Kern, Wolfgang|||0000-0002-6452-2874
  • Visconte, Valeria|||0000-0002-2993-1509
  • Sekeres, Mikkael|||0000-0003-2009-6524
  • Barnard, John|||0000-0003-2403-8268
  • Haferlach, T.|||0000-0003-0196-2837
  • Sole, F.|||0000-0002-3251-2161
  • Maciejewski, Jaroslaw|||0000-0002-6837-4346
Background: Haploinsufficiency (HI) resulting from deletion of the long arm of chromosome 5 [del(5q)] and the accompanied loss of heterozygosity are likely key pathogenic factors in del(5q) myeloid neoplasia (MN) although the consequences of del(5q) have not been yet clarified. Methods: Here, we explored mutations, gene expression and clinical phenotypes of 388 del(5q) vs. 841 diploid cases with MN [82% myelodysplastic syndromes (MDS)]. Findings: Del(5q) resulted as founder (better prognosis) or secondary hit (preceded by TP53 mutations). Using Bayesian prediction analyses on 57 HI marker genes we established the minimal del(5q) gene signature that distinguishes del(5q) from diploid cases. Clusters of diploid cases mimicking the del(5q) signature support the overall importance of del(5q) genes in the pathogenesis of MDS in general. Sub-clusters within del(5q) patients pointed towards the inherent intrapatient heterogeneity of HI genes. Interpretation: The underlying clonal expansion drive results from a balance between the "HI-driver" genes (e.g., CSNK1A1, CTNNA1, TCERG1) and the proapoptotic "HI-anti-drivers" (e.g., RPS14, PURA, SIL1). The residual essential clonal expansion drive allows for selection of accelerator mutations such as TP53 (denominating poor) and CSNK1A1 mutations (with a better prognosis) which overcome pro-apoptotic genes (e.g., p21, BAD, BAX), resulting in a clonal expansion. In summary, we describe the complete picture of del(5q) MN identifying the crucial genes, gene clusters and clonal hierarchy dictating the clinical course of del(5q) patients.